drugset / Trial / NCT02222168

Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy Volunteers

NCT02222168

Phase 1 Completed 18 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the effect of food on the pharmacokinetics of BI 409306 and to investigate the pharmacokinetics of BI 409306 when given at bed time.

Timeline

Start
2014-09-04
Primary completion
2014-10-31
Completion
2014-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject OSORESNONTRINE Small molecule 25 mg Oral

Indications

No indication recorded.